• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭质量和结局的区域差异:遵循指南-心力衰竭注册研究。

Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry.

机构信息

Integris Baptist Medical Center Oklahoma City OK.

David Geffen School of Medicine - University of California Los Angeles CA.

出版信息

J Am Heart Assoc. 2021 Apr 6;10(7):e018696. doi: 10.1161/JAHA.120.018696. Epub 2021 Mar 24.

DOI:10.1161/JAHA.120.018696
PMID:33759546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8174327/
Abstract

Background Regional patient characteristics, care quality, and outcomes may differ based on a variety of factors among patients hospitalized for heart failure (HF). Regional disparities in outcomes of cardiovascular disease have been suggested across various regions in the United States. This study examined whether there are significant differences by region in quality of care and short-term outcomes of hospitalized patients with HF across the United States. Methods and Results We examined regional demographics, quality measures, and short-term outcomes across 4 US Census Bureau regions in patients hospitalized with HF and enrolled in the GWTG-HF (Get With The Guidelines-Heart Failure) registry from 2010 to 2016. Differences in length of stay and mortality by region were examined with multivariable logistic regression. The study included 423 333 patients hospitalized for HF in 488 hospitals. Patients in the Northeast were significantly older. Completion of achievement measures, with few exceptions, were met with similar frequency across regions. Multivariable analysis demonstrated significantly lower in-hospital mortality in the Midwest compared with the Northeast (hazard ratio, 0.64; 95% CI, 0.51-0.8; <0.00001). The length of stay varied significantly by region with a significantly higher risk-adjusted length of stay in the Northeast compared with other regions. Conclusions Although we did not find any substantial differences by region in quality of care in patients hospitalized for HF, risk-adjusted inpatient mortality was found to be lower in the Midwest compared with the Northeast, and may be secondary to unmeasured differences in patient characteristics, and to longer length of stay in the Northeast.

摘要

背景

在美国的不同地区,由于患者的各种因素,区域性的患者特征、护理质量和结局可能存在差异。在心血管疾病的结果方面,已经提出了各个地区之间存在差异。本研究旨在探讨美国不同地区因心力衰竭(HF)住院患者的护理质量和短期结局是否存在显著差异。

方法和结果

我们研究了 2010 年至 2016 年期间在美国 4 个人口普查局区域内住院治疗 HF 并参加 GWTG-HF(获得指南-心力衰竭)登记处的患者的区域性人口统计学、质量指标和短期结局。使用多变量逻辑回归检验了区域间的住院时间和死亡率差异。研究共纳入了 423333 名因 HF 住院的患者,来自 488 家医院。东北区的患者年龄明显较大。除了少数例外,完成成就措施的比例在各个地区相似。多变量分析表明,与东北部相比,中西部地区的院内死亡率显著降低(危险比,0.64;95%置信区间,0.51-0.8;<0.00001)。住院时间在各个地区有显著差异,与其他地区相比,东北地区的风险调整后住院时间明显较高。

结论

尽管我们没有发现因 HF 住院患者的护理质量存在任何实质性的地区差异,但与东北部相比,中西部地区的风险调整后住院死亡率较低,这可能与患者特征的未测量差异以及东北地区的住院时间较长有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d8/8174327/1563e9b51de5/JAH3-10-e018696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d8/8174327/0a86e9e8b036/JAH3-10-e018696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d8/8174327/1563e9b51de5/JAH3-10-e018696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d8/8174327/0a86e9e8b036/JAH3-10-e018696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1d8/8174327/1563e9b51de5/JAH3-10-e018696-g001.jpg

相似文献

1
Regional Variations in Heart Failure Quality and Outcomes: Get With The Guidelines-Heart Failure Registry.心力衰竭质量和结局的区域差异:遵循指南-心力衰竭注册研究。
J Am Heart Assoc. 2021 Apr 6;10(7):e018696. doi: 10.1161/JAHA.120.018696. Epub 2021 Mar 24.
2
Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry.农村与城市美国医院心力衰竭住院患者的护理质量和结局:Get With The Guidelines-Heart Failure 注册研究。
JAMA Cardiol. 2023 Apr 1;8(4):376-385. doi: 10.1001/jamacardio.2023.0241.
3
Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.与因心力衰竭入院患者的医院容量、护理过程和结局之间的关联:来自 Get With The Guidelines-Heart Failure 的见解。
Circulation. 2018 Apr 17;137(16):1661-1670. doi: 10.1161/CIRCULATIONAHA.117.028077. Epub 2018 Jan 29.
4
Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry.COVID-19 大流行期间心力衰竭的护理质量和院内结局:来自 Get With The Guidelines-Heart Failure 注册研究的结果。
Eur J Heart Fail. 2022 Jun;24(6):1117-1128. doi: 10.1002/ejhf.2484. Epub 2022 Apr 6.
5
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry.基于 30 天风险标准化死亡率的医院绩效与心力衰竭住院后长期生存的关联:对 Get With The Guidelines-Heart Failure 注册研究的分析。
JAMA Cardiol. 2018 Jun 1;3(6):489-497. doi: 10.1001/jamacardio.2018.0579.
6
Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF).心力衰竭非依从性患者的特征及院内结局:来自“遵循指南-心力衰竭(GWTG-HF)”的研究结果
Am Heart J. 2009 Oct;158(4):644-52. doi: 10.1016/j.ahj.2009.07.034.
7
Association of the Affordable Care Act's Medicaid Expansion With Care Quality and Outcomes for Low-Income Patients Hospitalized With Heart Failure.《平价医疗法案》的医疗补助扩大计划与因心力衰竭住院的低收入患者的护理质量及治疗结果的关联
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004729. doi: 10.1161/CIRCOUTCOMES.118.004729.
8
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).糖尿病对心力衰竭住院患者特征及预后的影响:来自心力衰竭住院患者启动挽救生命治疗组织项目(OPTIMIZE-HF)的报告
Am Heart J. 2007 Aug;154(2):277.e1-8. doi: 10.1016/j.ahj.2007.05.001.
9
Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines.医院间心力衰竭住院患者静脉使用正性肌力药物的差异:来自 Get With The Guidelines 的观察
Circ Heart Fail. 2014 Mar 1;7(2):251-60. doi: 10.1161/CIRCHEARTFAILURE.113.000761. Epub 2014 Jan 31.
10
Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes.医院再入院减少计划下心力衰竭 30 天再入院指标与医疗质量和结果的关系。
JACC Heart Fail. 2016 Dec;4(12):935-946. doi: 10.1016/j.jchf.2016.07.003.

引用本文的文献

1
Trends and disparities in heart failure mortality with and without chronic kidney disease in a nationwide retrospective analysis.一项全国性回顾性分析中伴或不伴慢性肾脏病的心力衰竭死亡率的趋势与差异
Sci Rep. 2025 Aug 8;15(1):29103. doi: 10.1038/s41598-025-04056-7.
2
Early Initiation of Guideline-Directed Medical Therapy Improves Outcomes in Heart Failure with Reduced Ejection Fraction Patients without Significant Risk of Nephrotoxicity.早期启动指南导向的药物治疗可改善射血分数降低的心力衰竭患者的预后,且这些患者无显著肾毒性风险。
Acta Cardiol Sin. 2025 Jul;41(4):510-520. doi: 10.6515/ACS.202507_41(4).20250324A.
3
Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead.

本文引用的文献

1
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭的药物治疗滴定。
J Am Coll Cardiol. 2019 May 21;73(19):2365-2383. doi: 10.1016/j.jacc.2019.02.015. Epub 2019 Mar 4.
2
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
3
Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure.
《遵循心力衰竭治疗指南:二十年回顾、经验教训与未来之路》
Circ Heart Fail. 2025 May 12:e012936. doi: 10.1161/CIRCHEARTFAILURE.125.012936.
4
Temporal trends in heart failure and acute kidney injury-related mortality in the U.S.: a 21-year retrospective analysis of the CDC WONDER database.美国心力衰竭和急性肾损伤相关死亡率的时间趋势:对疾病控制与预防中心(CDC)WONDER数据库的21年回顾性分析
Int Urol Nephrol. 2025 Apr 25. doi: 10.1007/s11255-025-04534-x.
5
Accountable Care Organization Participation and Cardiovascular Care Quality.accountable care organization参与和心血管护理质量。 (注:Accountable Care Organization常见释义为“ accountable care organization”,直译为“ accountable care organization”,在医疗领域常指“ accountable care organization”,是一种新型医疗服务模式,强调医疗服务的协调与整合,以提高医疗质量和控制成本。为使译文更符合中文表达习惯,可调整为“ accountable care organization参与和心血管护理质量。 ” )
JAMA Cardiol. 2025 Apr 2. doi: 10.1001/jamacardio.2025.0381.
6
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.欧洲心力衰竭:在慢性和急性、既往存在和新发的射血分数降低、轻度降低和保留的心力衰竭中,遵循指南的药物治疗应用及决策制定——欧洲心脏病学会(ESC)欧洲心力衰竭调查研究项目(EORP)心力衰竭III注册研究
Eur J Heart Fail. 2024 Dec;26(12):2487-2501. doi: 10.1002/ejhf.3445. Epub 2024 Sep 10.
7
County-Level Variation in Triple Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭患者三联指南指导药物治疗的县级差异
JACC Adv. 2024 Jun 12;3(7):101014. doi: 10.1016/j.jacadv.2024.101014. eCollection 2024 Jul.
8
Epidemiology and Burden of Heart Failure in Asia.亚洲心力衰竭的流行病学与负担
JACC Asia. 2024 Mar 19;4(4):249-264. doi: 10.1016/j.jacasi.2024.01.013. eCollection 2024 Apr.
9
Short-Term Mortality in Hospitalized Patients with Congestive Heart Failure: Markers of Thrombo-Inflammation Are Independent Risk Factors and Only Weakly Associated with Renal Insufficiency and Co-Morbidity Burden.充血性心力衰竭住院患者的短期死亡率:血栓炎症标志物是独立危险因素,且仅与肾功能不全和合并症负担存在微弱关联。
J Cardiovasc Dev Dis. 2024 Mar 20;11(3):93. doi: 10.3390/jcdd11030093.
10
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.中国心力衰竭患者的性能指标与临床结局之间的关联:HERO研究结果
Clin Cardiol. 2024 Feb;47(2):e24233. doi: 10.1002/clc.24233.
指南发布对心力衰竭住院患者使用血管紧张素受体脑啡肽酶抑制剂的早期影响。
Am Heart J. 2018 Jun;200:134-140. doi: 10.1016/j.ahj.2018.01.009. Epub 2018 Jan 31.
4
Regional Variation in Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014).美国左心室辅助装置植入术后死亡率、主要并发症及费用的地区差异(2009年至2014年)
Am J Cardiol. 2018 Jun 15;121(12):1575-1580. doi: 10.1016/j.amjcard.2018.02.047. Epub 2018 Apr 13.
5
National Trends in Admission and In-Hospital Mortality of Patients With Heart Failure in the United States (2001-2014).美国心力衰竭患者入院和住院死亡率的国家趋势(2001-2014 年)。
J Am Heart Assoc. 2017 Nov 29;6(12):e006955. doi: 10.1161/JAHA.117.006955.
6
Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure.医院再入院率降低计划实施与心力衰竭患者再入院和死亡率结局的关联。
JAMA Cardiol. 2018 Jan 1;3(1):44-53. doi: 10.1001/jamacardio.2017.4265.
7
Regional Variation in Mortality, Length of Stay, Cost, and Discharge Disposition Among Patients Admitted for Heart Failure in the United States.美国心力衰竭住院患者的死亡率、住院时间、费用及出院处置的地区差异
Am J Cardiol. 2017 Sep 1;120(5):817-824. doi: 10.1016/j.amjcard.2017.05.058. Epub 2017 Jun 15.
8
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新:美国心脏病学会/美国心脏协会临床实践指南特别工作组及美国心力衰竭学会的报告
Circulation. 2017 Aug 8;136(6):e137-e161. doi: 10.1161/CIR.0000000000000509. Epub 2017 Apr 28.
9
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction: Insights From Get With the Guidelines-Heart Failure (GWTG-HF).沙库巴曲缬沙坦在射血分数降低的心力衰竭患者中的早期应用:来自“遵循指南-心力衰竭(GWTG-HF)”的见解。
JACC Heart Fail. 2017 Apr;5(4):305-309. doi: 10.1016/j.jchf.2016.12.018.
10
Utility of socioeconomic status in predicting 30-day outcomes after heart failure hospitalization.社会经济地位在预测心力衰竭住院后30天结局中的作用。
Circ Heart Fail. 2015 May;8(3):473-80. doi: 10.1161/CIRCHEARTFAILURE.114.001879. Epub 2015 Mar 6.